Corona: In the crisis, his expertise is in demand: Virologist Christian Drosten spoke in a new episode of the NDR podcast about Corona apps and a possible medication.
- Virologist Christian Drosten commented on the current situation in Germany .
- He spoke intensively about apps and a drug that is currently being tested.
- Here you will find the basic facts about the corona virus * and the corona news from Germany *. You can also find current case numbers * in Germany as a map. The following recommendations for corona protective measures are currently available.
Hamburg - The corona virus * and its consequences have Germany firmly under control. The exit restrictions and contact bans that have been in effect for a good two weeks apply nationwide, although not quite uniformly. In the NDR podcast "The Corona Virus Update with Christian Drosten", the virologist talks about the current happenings around the virus. Friday was also about apps and the drug chloroquine .
Virologist Drosten: App could take over "part of the work of the health department"
Drosten criticized the fact that current intervention options such as “easy identification of cases and contact tracking come too late.” Calculations and identification take too long, and potentially infected patients that you want to identify may already have “lost”.
Drosten is a supporter of a comprehensive reporting system in the form of a cell phone app. The " hypothetical app " would record symptoms and send them to laboratories. "The app would trigger a diagnostic process," said Drosten. "At that moment, the app can start tracking what other cell phones you have been in contact with."
Virologist Drosten warns of side effects from chloroquine
In this way, other users could determine possible contact with a user with symptoms. "In principle, part of the work of the health department is transferred to the app." This would also save time, according to a survey, 47 percent of Germans would use it. The mobile app called Drosten a "glimmer of hope".
There was also talk of a study on the drug chloroquine . However, Drosten is skeptical because the malaria drug has "serious side effects", it would still remain "under discussion".
Virologist Drosten: Malaria drug chloroquine "is a weak solution"
Drosten then rates the success of a study. In the study, two groups of patients of the same size were used; one group was given the drug. "What you find is that pneumonia in the untreated group improves after 17 days in 17 out of 31 cases . In the treatment group, signs of pneumonia get better in 25 out of 31 cases. ”Drosten noted that one was not sure whether“ the study was not too small. ”
In conclusion, he said, “If chloroquine is a solution, it is a weak solution. You don't gain much. "
List of rubric lists: © dpa / Michael Kappeler